Moderna Inc. shares declined as the company’s cost-cutting efforts failed to assuage investors who are worried about the ...

Moderna beat Q2 earnings and revenue estimates, narrowed its annual forecast, won a key patent case, and plans to cut 10% of ...

The layoffs are part of an ongoing effort to reduce operating costs amid government and competitive challenges to its vaccine ...

Three times as much taxpayer cash was spent advertising the LNP government’s politically-charged Hospital Rescue Plan than ...

Moderna (MRNA) stock drops even after beating Q2 2025 forecasts, as it lowered the top end of the revenue outlook due to ...

Moderna surpassed Wall Street sales predictions due to strong Spring COVID booster demand but lowered its 2025 sales forecast, causing a premarket share decline. Despite a 41% revenue drop to $142 ...

(NASDAQ:MRNA) today reported financial results and provided business updates for the second quarter of 2025. "In the last three months, we advanced our pipeline with positive Phase 3 flu vaccine ...

Question: Thank goodness that tsunami was not a big deal after all. Would homeowner’s insurance even cover that?

Moderna topped Wall Street sales expectations and reported a lower-than-expected second-quarter loss on Friday, driven by ...

Despite the irresponsible “political” noise surrounding the matter, vaccines remain an important step for parents to take in keeping their children as healthy and safe as possible. For those with ...

It’s time to get back to the classroom - but for students who suffer from asthma, a new school year can be challenging in ...